Frequently Asked Questions about Greenwich LifeSciences, Inc. (GLSI)

Name: Greenwich LifeSciences, Inc. (GLSI) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Greenwich LifeSciences, Inc. (GLSI) do?

Accepted Answer

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to preve...

Question 2

Is Greenwich LifeSciences, Inc. (GLSI) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of GLSI reveals an Altman Z-Score of 72.19 and a Piotroski F-Score of 1/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if GLSI fits their risk profile.

Question 3

What is the current P/E ratio for GLSI?

Accepted Answer

As of the latest trading session, Greenwich LifeSciences, Inc. (GLSI) has a trailing P/E ratio of -15.32.

Question 4

Who is the CEO of Greenwich LifeSciences, Inc.?

Accepted Answer

The current Chief Executive Officer of Greenwich LifeSciences, Inc. is Snehal S. Patel.

Question 5

What was GLSI's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Greenwich LifeSciences, Inc. reported annual revenues of $0.00B (2024), $0.00B (2023), $0.00B (2022), $0.00B (2021), $0.00B (2020) respectively.

Question 6

Does GLSI pay a dividend?

Accepted Answer

Greenwich LifeSciences, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does GLSI have?

Accepted Answer

In its latest reporting period, Greenwich LifeSciences, Inc. generated $-0.01B in Free Cash Flow against a total debt load of $N/A.

Question 8

What is the Price-to-Book (P/B) ratio of Greenwich LifeSciences, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Greenwich LifeSciences, Inc. (GLSI) is currently 136.54.

Question 9

What is the Price-to-Sales (P/S) ratio of GLSI?

Accepted Answer

Based on trailing twelve-month data, Greenwich LifeSciences, Inc. (GLSI) trades at a Price-to-Sales (P/S) ratio of 0.00.

Question 10

What is Greenwich LifeSciences, Inc.'s Return on Equity (ROE)?

Accepted Answer

Greenwich LifeSciences, Inc. (GLSI) has a Return on Equity (ROE) of -1042.76%, representing its profitability relative to shareholder equity.